2026 NPPES data Urology Physician NPI 1659559003 M.P.H.,M.D.
Verify on CMS →

PRIYA PADMANABHAN, M.P.H.,M.D.

Urology Physician in ROYAL OAK, Michigan. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 401 beneficiaries · Urology Physician avg: 1K
Generic prescribing
77%
generic claims · 23% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$345.9
5 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

PRIYA PADMANABHAN, M.P.H.,M.D. filed 1,194 Medicare Part D claims in 2023 as a Urology Physician in ROYAL OAK, Michigan, prescribing 77% generic.

1K
Part D claims, 2023
77%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

PRIYA PADMANABHAN, M.P.H.,M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

1,194 Top 23% higher than 77% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). This entry sits in this band. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

PRIYA PADMANABHAN, M.P.H.,M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about PRIYA PADMANABHAN, M.P.H.,M.D.?

Quality data not reported

NPI registry status

Active

Issued 02/07/2008

NPI 1659559003

Primary specialty

Urology Physician

Mid-sized

13,350 US NPIs in this specialty

Medicare Part D claims

1,194 7% vs specialty avg

2023 prescription claims

Specialty avg: 1,280

Specialty distribution in Michigan

How Urology Physician compares to other specialties among Michigan providers

Michigan providers

Urology Physician share within Michigan

1. Urology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Urology Physician share within Michigan

Specialty board-certification context

Estimated specialty board-certified rate — Urology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Urology Physician ABMS/AOA estimate

Est. board-certified rate (Urology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Urology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

PRIYA PADMANABHAN, M.P.H.,M.D. is a Urology Physician provider practicing in ROYAL OAK, Michigan, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.P.H.,M.D.. NPI: 1659559003. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

PRIYA PADMANABHAN, M.P.H.,M.D. appears in the CMS NPPES registry as a Urology Physician provider holding M.P.H.,M.D. credentials at 3601 W 13 MILE RD, ROYAL OAK, MI, 48073, with a listed phone of (248) 898-0898. NPI 1659559003 was issued on 02/07/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what PADMANABHAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,194 prescription claims written by this provider, covering 401 Medicare beneficiaries and totaling roughly $312K in drug spend, split 23% brand-name and 77% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Urology Physician is a mid-sized specialty nationwide, with 13,350 enrolled providers across 54 states and an average of 1,280 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

3601 W 13 MILE RD
ROYAL OAK, MI 48073

Provider Details

NPI 1659559003
Specialty Urology Physician
Credentials M.P.H.,M.D.
Gender Female
NPI Issued 02/07/2008

Hospital and facility affiliations

Facilities where PRIYA PADMANABHAN, M.P.H.,M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

BEAUMONT MEDICAL GROUP- SPECIALTY SERVICES
FARMINGTON HILLS, MI

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for PRIYA PADMANABHAN, M.P.H.,M.D.. Source: openpaymentsdata.cms.gov.

Total received

$346

Largest payer

Medtronic, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Michigan MI-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~41K Michigan medical licensees in 2023 — they are NOT specific to PRIYA PADMANABHAN, M.P.H.,M.D.. To verify PRIYA PADMANABHAN, M.P.H.,M.D.'s current license status, search the MI-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

123
Total board actions, Michigan 2023
Across 120 cases
3.00
Actions per 1,000 licensees
Michigan statewide rate
probation
Most common action type
44 cases

MI-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Michigan disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

PRIYA PADMANABHAN, M.P.H.,M.D. — brand share 23.0%
Specialty average (est.)

23% brand-name claims vs 77% generic, on 1,194 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,194
Total Claims
$312K
Total Drug Cost
401
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,399
Total Day Supply
67,542
Brand vs Generic
23% brand / 77% generic
Brand Drug Cost
$228K
Generic Drug Cost
$83K
Antibiotic Claims
153

Patient Demographics

Average Patient Age
75.7 years
Avg HCC Risk Score
1.34
Gender Split
91% female / 9% male
Age Distribution
<65: 26, 65-74: 149, 75-84: 153, 85+: 73

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Estradiol
509
Myrbetriq
Mirabegron
228
Trospium Chloride Er
Trospium Chloride
87
Trospium Chloride
62
Nitrofurantoin Mono-Macro
Nitrofurantoin Monohyd/M-Cryst
56
Tamsulosin Hcl
44
Sulfamethoxazole-Trimethoprim
Sulfamethoxazole/Trimethoprim
42
Cephalexin
36
Oxybutynin Chloride Er
Oxybutynin Chloride
23
Finasteride
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Urology Physician Overview

How PRIYA PADMANABHAN, M.P.H.,M.D. fits within the Urology Physician landscape nationally.

13,350
Urology Physician Providers in US
54
States with Urology Physician
1,280
Avg Claims per Provider

PRIYA PADMANABHAN, M.P.H.,M.D.'s 1,194 claims are below the specialty average of 1,280.

Nearby Urology Physician Providers in Michigan

Other clinicians with the same primary specialty enrolled in Michigan, drawn from the same CMS NPPES roster as PADMANABHAN.

Compare Urology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is PRIYA PADMANABHAN, M.P.H.,M.D.'s specialty?
PRIYA PADMANABHAN, M.P.H.,M.D. specializes in Urology Physician and practices in ROYAL OAK, Michigan. Credentials: M.P.H.,M.D..
How much does PRIYA PADMANABHAN, M.P.H.,M.D. prescribe under Medicare Part D?
In 2023, PRIYA PADMANABHAN, M.P.H.,M.D. wrote 1,194 Medicare Part D claims totaling $312K in drug costs for 401 beneficiaries.
Where is PRIYA PADMANABHAN, M.P.H.,M.D. located?
PRIYA PADMANABHAN, M.P.H.,M.D. is located at 3601 W 13 MILE RD, ROYAL OAK, MI, 48073. Phone: (248) 898-0898.
What is PRIYA PADMANABHAN, M.P.H.,M.D.'s NPI number?
PRIYA PADMANABHAN, M.P.H.,M.D.'s National Provider Identifier (NPI) is 1659559003, issued on 02/07/2008.
Does PRIYA PADMANABHAN, M.P.H.,M.D. prescribe more brand-name or generic drugs?
PRIYA PADMANABHAN, M.P.H.,M.D.'s prescribing is 23% brand-name and 77% generic drugs by claim count, with $228K in brand drug costs.
How many Urology Physician providers are there in the US?
There are 13,350 Urology Physician providers across 54 states in the US. The average Urology Physician provider writes 1,280 Medicare Part D claims per year.
What drugs does PRIYA PADMANABHAN, M.P.H.,M.D. prescribe most often?
Based on 2023 Medicare Part D data, PRIYA PADMANABHAN, M.P.H.,M.D.'s most frequently prescribed drugs include Estradiol, Myrbetriq, Trospium Chloride Er. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does PRIYA PADMANABHAN, M.P.H.,M.D. accept Medicare?
PRIYA PADMANABHAN, M.P.H.,M.D. appears in CMS Medicare data with 1,194 Part D claims and 401 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify PRIYA PADMANABHAN, M.P.H.,M.D.'s credentials?
PRIYA PADMANABHAN, M.P.H.,M.D.'s NPI is 1659559003 with credentials M.P.H.,M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology